Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
Authors
Keywords
Gastric cancer, HER2, c-erbB2, Prognosis, Metabolism
Journal
Gastric Cancer
Volume 19, Issue 2, Pages 421-430
Publisher
Springer Nature
Online
2015-05-23
DOI
10.1007/s10120-015-0504-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic pathways promoting cancer cell survival and growth
- (2015) Lindsey K. Boroughs et al. NATURE CELL BIOLOGY
- Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma
- (2014) Jihun Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Optimal chemotherapy for advanced gastric cancer: is there a global consensus?
- (2013) Florian Lordick et al. Gastric Cancer
- HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation
- (2013) Miao-Zhen Qiu et al. INTERNATIONAL JOURNAL OF CANCER
- HER2 in resected gastric cancer: Is there prognostic value?
- (2013) Sarah B. Fisher et al. JOURNAL OF SURGICAL ONCOLOGY
- Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
- (2013) Hugo E R Ford et al. LANCET ONCOLOGY
- Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
- (2012) Y. Y. Janjigian et al. ANNALS OF ONCOLOGY
- Gastrointestinal Adenocarcinomas of the Esophagus, Stomach, and Colon Exhibit Distinct Patterns of Genome Instability and Oncogenesis
- (2012) A. M. Dulak et al. CANCER RESEARCH
- Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment
- (2012) Kohei Shitara et al. Gastric Cancer
- A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
- (2012) Niantao Deng et al. GUT
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
- (2012) Jung Hun Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
- (2012) Carlos Gómez-Martin et al. JOURNAL OF CLINICAL PATHOLOGY
- Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
- (2012) Hongyoon Choi et al. LUNG CANCER
- New aspects of the Warburg effect in cancer cell biology
- (2012) Steven J. Bensinger et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes-A systematic review
- (2011) Terence C. Chua et al. INTERNATIONAL JOURNAL OF CANCER
- Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response
- (2011) Aizhi Zhu et al. SEMINARS IN ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- The role of PET/CT in detection of gastric cancer recurrence
- (2009) Sung Hoon Sim et al. BMC CANCER
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now